The effect of δ-9-tetrahydrocannabinol on forebrain ischemia in rat

Brain Research

Volumn 857, Issue 1-2, 2000, Pages 183-187

  Louw, Deon F ^a   Yang, Fang W ^a   Sutherland, Garnette R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

9 tetrahydrocannabinol; Forebrain ischemia; Hippocampus; Striatum

Indexed keywords

CANNABINOID RECEPTOR; DRONABINOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG MEGADOSE; FOREBRAIN; HIPPOCAMPUS; HISTOPATHOLOGY; NEOCORTEX; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ISCHEMIA; MALE; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; PSYCHOTROPIC DRUGS; RATS; TETRAHYDROCANNABINOL;

EID: 0033969895     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02422-1     Document Type: Article

References (16)

1. Belayev L., Bar-Joseph A., Adamchik J., Biegon A. HU-211, A nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats. Mol. Chem. Neuropathol. 25:1995;19-33.
2. Belayev L., Busto R., Zhao W., Ginsberg M.D. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke. 26:1995;2313-2319.
3. de Kay, D., Hemp, Encyclopedia Americana 14, 1959, 91.
4. Herkenham M., Lynn A.B., Johnson M.B., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
5. Howlett A.C., Bidaut-Russell M., Devane W.A., Melvin L.S., Johnson M.R., Herkenham M. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13:1990;420-423.
6. Kluin-Nelemans J.C., Meuwissen O.J., Nelemans F.A., Maes R.A. Delta-9-tetrahydrocannabinol (THC) as an antiemetic. New Engl. J. Med. 302:1980;1364-1365.
7. Luvisotto T., Auer R.N., Sutherland G.R. The effect of mannitol on cerebral ischemia - revisited. Neurosurgery. 38:1996;131-139.
8. Marx J. Marijuana receptor gene cloned. Science. 249:1990;624-626.
9. Mathew R.J., Wilson W.H., Humphreys D.F., Lowe J.V., Wiethe J.E. Regional cerebral blood flow after marijuana smoking. J. Cereb. Blood Flow Metab. 12:1992;750-758.
10. Maurer M., Henn V., Dittrich A., Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur. Arch. Psychiatry Neurol. Sci. 320:1989;1.
11. 2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211 Brain Res. 685:1993;79-85.
12. Petro D.J., Ellenberger C. Jr. Treatment of human spasticity with delta 9-tetrahydrocannabinol. J. Clin. Pharmacol. 21:1981;413-416S.
13. Rabin O., Chang M.C.J., Grange E., Bell J., Rapoport S.I., Deutsch J., Purdon A.D. Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipid following transient ischemia in awake gerbil. J. Neurochem. 70:1998;325-334.
14. Sutherland G.R., Peeling J., Lesiak H.J., Brownstone R.M., Rydzy M., Saunders J.K., Geiger J.D. The effect of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience. 42:1991;171-182.
15. Sutherland G.R., Lesiuk H., Hazendonk P., Peeling J., Kozlowski P., Jazinski A., Saunders J.K. Magnetic resonance imaging and 31P spectroscopy study of the effect of temperature on ischemic brain injury. Can. J. Neurol. Sci. 19:1992;317-325.
16. Zhuang S., Kittler J., Grigorenko E.V., Kirby M.T., Sim L.J., Hampton R.E., Childers S.R., Deadwyler S.A. Brain Res. Mol. Brain Res. 46:1998;141-149.